Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of tlr4 during sepsis

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 5152-5160

  Deng, Meihong ^a   Scott, Melanie J ^a   Loughran, Patricia ^a,b   Gibson, Gregory ^b   Sodhi, Chhinder ^a,c   Watkins, Simon ^b   Hackam, David ^a,c   Billiar, Timothy R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COUNT; BACTERIUM CULTURE; BONE MARROW CELL; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; ESCHERICHIA COLI; IMMUNE RESPONSE; LIVER CELL; LIVER INJURY; MACROPHAGE; MALE; MORBIDITY; MOUSE; NONHUMAN; PATTERN RECOGNITION; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; BACTERIAL LOAD; CECUM; CELLS, CULTURED; HEPATOCYTES; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; NEUTROPHILS; PHAGOCYTOSIS; SEPSIS; SURVIVAL; TOLL-LIKE RECEPTOR 4;

EID: 84877820843     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300496     Document Type: Article

References (60)

1. Tidswell, M., and S. P. LaRosa. 2011. Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis. Expert Rev. Anti Infect. Ther. 9: 507-520.
2. Wiersinga, W. J. 2011. Current insights in sepsis: from pathogenesis to new treatment targets. Curr. Opin. Crit. Care 17: 480-486.
3. Carpenter, S., and L. A. O'Neill. 2007. How important are Toll-like receptors for antimicrobial responses? Cell. Microbiol. 9: 1891-1901. (Pubitemid 47087081)
4. Vodovotz, Y., S. Liu, C. McCloskey, R. Shapiro, A. Green, and T. R. Billiar. 2001. The hepatocyte as a microbial product-responsive cell. J. Endotoxin Res. 7: 365-373. (Pubitemid 34048537)
5. Bauer, S., T. Muller, and S. Hamm. 2009. Pattern recognition by Toll-like receptors. Adv. Exp. Med. Biol. 653: 15-34.
6. Chen, Y., and R. Sun. 2011. Toll-like receptors in acute liver injury and regeneration. Int. Immunopharmacol. 11: 1433-1441.
7. Arslan, F., D. P. de Kleijn, and G. Pasterkamp. 2011. Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 8: 292-300.
8. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189: 1777-1782. (Pubitemid 29272694)
9. Scott, M. J., and T. R. Billiar. 2008. Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes. J. Biol. Chem. 283: 29433-29446.
10. Tsai, T. H., S. F. Chen, T. Y. Huang, C. F. Tzeng, A. S. Chiang, Y. R. Kou, T. S. Lee, and S. K. Shyue. 2011. Impaired Cd14 and Cd36 expression, bacterial clearance, and Toll-like receptor 4-Myd88 signaling in caveolin-1-deleted macrophages and mice. Shock 35: 92-99.
11. Wiersinga, W. J., C. W. Wieland, J. J. Roelofs, and T. van der Poll. 2008. MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS ONE 3: e3494.
12. Cai, S., S. Batra, L. Shen, N. Wakamatsu, and S. Jeyaseelan. 2009. Both TRIFand MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J. Immunol. 183: 6629-6638.
13. Fukata, M., K. S. Michelsen, R. Eri, L. S. Thomas, B. Hu, K. Lukasek, C. C. Nast, J. Lechago, R. Xu, Y. Naiki, et al. 2005. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G1055-G1065. (Pubitemid 40563149)
14. Hassan, F., D. Ren, W. Zhang, T. J. Merkel, and X. X. Gu. 2012. Moraxella catarrhalis activates murine macrophages through multiple toll like receptors and has reduced clearance in lungs from TLR4 mutant mice. PLoS ONE 7: e37610.
15. Anand, R. J., J. W. Kohler, J. A. Cavallo, J. Li, T. Dubowski, and D. J. Hackam. 2007. Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis. J. Pediatr. Surg. 42: 927-932, discussion 933.
16. Wolfe, D. N., A. M. Buboltz, and E. T. Harvill. 2009. Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS ONE 4: e4280.
17. Kimmoun, A., and B. Levy. 2011. Treatment of myocardial dysfunction in sepsis: the Toll-like receptor antagonist approach. Shock 36: 633-634.
18. Figueroa, L., Y. Xiong, C. Song, W. Piao, S. N. Vogel, and A. E. Medvedev. 2012. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J. Immunol. 188: 4506-4515.
19. Lorenz, E., M. Hallman, R. Marttila, R. Haataja, and D. A. Schwartz. 2002. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr. Res. 52: 373-376. (Pubitemid 34920267)
20. Dory, D., H. Echchannaoui, M. Letiembre, F. Ferracin, J. Pieters, Y. Adachi, S. Akashi, W. Zimmerli, and R. Landmann. 2003. Generation and functional characterization of a clonal murine periportal Kupffer cell line from H-2Kb -tsA58 mice. J. Leukoc. Biol. 74: 49-59. (Pubitemid 38040436)
21. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Fo rster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277. (Pubitemid 29523965)
22. Takeda, K., B. E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster, and S. Akira. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10: 39-49. (Pubitemid 29077382)
23. Postic, C., M. Shiota, K. D. Niswender, T. L. Jetton, Y. Chen, J. M. Moates, K. D. Shelton, J. Lindner, A. D. Cherrington, and M. A. Magnuson. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274: 305-315. (Pubitemid 29035064)
24. Stiles, B., Y. Wang, A. Stahl, S. Bassilian, W. P. Lee, Y. J. Kim, R. Sherwin, S. Devaskar, R. Lesche, M. A. Magnuson, and H. Wu. 2004. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. [Published erratum appears in 2004 Proc. Natl. Acad. Sci. USA 101: 5180.] Proc. Natl. Acad. Sci. USA 101: 2082-2087.
25. Sodhi, C. P., M. D. Neal, R. Siggers, S. Sho, C. Ma, M. F. Branca, T. Prindle, Jr., A. M. Russo, A. Afrazi, M. Good, et al. 2012. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 143: 708-718.e1-5.
26. Scott, M. J., S. Liu, G. L. Su, Y. Vodovotz, and T. R. Billiar. 2005. Hepatocytes enhance effects of lipopolysaccharide on liver nonparenchymal cells through close cell interactions. Shock 23: 453-458. (Pubitemid 40571669)
27. Zarember, K. A., and P. J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168: 554-561. (Pubitemid 34049553)
28. Pinsky, M. R. 2001. Sepsis: a pro-And anti-inflammatory disequilibrium syndrome. Contrib. Nephrol. (132): 354-366.
29. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189: 615-625. (Pubitemid 29193362)
30. Faure, K., T. Sawa, T. Ajayi, J. Fujimoto, K. Moriyama, N. Shime, and J. P. Wiener-Kronish. 2004. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir. Res. 5: 1.
31. Haziot, A., N. Hijiya, S. C. Gangloff, J. Silver, and S. M. Goyert. 2001. Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice. J. Immunol. 166: 1075-1078. (Pubitemid 32060265)
32. Lee, J. S., C. W. Frevert, G. Matute-Bello, M. M. Wurfel, V. A. Wong, S. M. Lin, J. Ruzinski, S. Mongovin, R. B. Goodman, and T. R. Martin. 2005. TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L731-L738. (Pubitemid 41504404)
33. Romero, C. D., T. K. Varma, J. B. Hobbs, A. Reyes, B. Driver, and E. R. Sherwood. 2011. The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection. Infect. Immun. 79: 3576-3587.
34. Roger, T., C. Froidevaux, D. Le Roy, M. K. Reymond, A. L. Chanson, D. Mauri, K. Burns, B. M. Riederer, S. Akira, and T. Calandra. 2009. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 106: 2348-2352.
35. Alves-Filho, J. C., A. de Freitas, M. Russo, and F. Q. Cunha. 2006. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34: 461-470. (Pubitemid 43145627)
36. Echtenacher, B., M. A. Freudenberg, R. S. Jack, and D. N. Mannel. 2001. Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect. Immun. 69: 7271-7276. (Pubitemid 33086548)
37. Sha, T., Y. Iizawa, and M. Ii. 2011. Combination of imipenem and TAK-242, a Toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis. Shock 35: 205-209.
38. Morrison, D. C., and J. L. Ryan. 1979. Bacterial endotoxins and host immune responses. Adv. Immunol. 28: 293-450.
39. Coutinho, A., L. Forni, F. Melchers, and T. Watanabe. 1977. Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur. J. Immunol. 7: 325-328. (Pubitemid 8111306)
40. Rittirsch, D., M. S. Huber-Lang,M. A. Flierl, and P. A.Ward. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4: 31-36.
41. Ayala, A., C. S. Chung, J. L. Lomas, G. Y. Song, L. A. Doughty, S. H. Gregory, W. G. Cioffi, B. W. LeBlanc, J. Reichner, H. H. Simms, and P. S. Grutkoski. 2002. Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am. J. Pathol. 161: 2283-2294. (Pubitemid 35434872)
42. Dear, J. W., H. Yasuda, X. Hu, S. Hieny, P. S. Yuen, S. M. Hewitt, A. Sher, and R. A. Star. 2006. Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int. 69: 832-836.
43. Castoldi, A., T. T. Braga, M. Correa-Costa, C. F. Aguiar, E. J. Bassi, R. Correa-Silva, R. M. Elias, F. Salvador, P. M. Moraes-Vieira, M. A. Cenedeze, et al. 2012. TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis. PLoS ONE 7: e37584.
44. Peck-Palmer, O. M., J. Unsinger, K. C. Chang, C. G. Davis, J. E. McDunn, and R. S. Hotchkiss. 2008. Deletion of MyD88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival. J. Leukoc. Biol. 83: 1009-1018. (Pubitemid 351959882)
45. Clark, S. R., A. C. Ma, S. A. Tavener, B. McDonald, Z. Goodarzi, M. M. Kelly, K. D. Patel, S. Chakrabarti, E. McAvoy, G. D. Sinclair, et al. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13: 463-469. (Pubitemid 46559832)
46. Wynn, J. L., P. O. Scumpia, R. D. Winfield, M. J. Delano, K. Kelly-Scumpia, T. Barker, R. Ungaro, O. Levy, and L. L. Moldawer. 2008. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 112: 1750-1758.
47. Mathison, J. C., and R. J. Ulevitch. 1979. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J. Immunol. 123: 2133-2143. (Pubitemid 10194464)
48. Mori, K., K. Matsumoto, and H. Gans. 1973. On the in vivo clearance and detoxification of endotoxin by lung and liver. Ann. Surg. 177: 159-163.
49. Fox, E. S., P. Thomas, and S. A. Broitman. 1987. Comparative studies of endotoxin uptake by isolated rat Kupffer and peritoneal cells. Infect. Immun. 55: 2962-2966. (Pubitemid 18008265)
50. Husebye, H., O. Halaas, H. Stenmark, G. Tunheim, O. Sandanger, B. Bogen, A. Brech, E. Latz, and T. Espevik. 2006. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 25: 683-692. (Pubitemid 43292431)
51. Mimura, Y., S. Sakisaka, M. Harada, M. Sata, and K. Tanikawa. 1995. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology 109: 1969-1976.
52. Scott, M. J., S. Liu, R. A. Shapiro, Y. Vodovotz, and T. R. Billiar. 2009. Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism. Hepatology 49: 1695-1708.
53. Ghermay, A. P., S. Brady, R. J. Havel, H. W. Harris, and J. H. Rapp. 1996. Sepsis increases endocytosis of endotoxin into hepatocytes. Surgery 120: 389-393, discussion 393-394.
54. Shao, B., R. S. Munford, R. Kitchens, and A. W. Varley. 2012. Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes. Innate Immun. 18: 825-833.
55. Harris, H. W., S. E. Brady, and J. H. Rapp. 2002. Hepatic endosomal trafficking of lipoprotein-bound endotoxin in rats. J. Surg. Res. 106: 188-195.
56. Kasravi, F. B., W. J. Brecht, K. H. Weisgraber, and H. W. Harris. 2003. Induction of cytokine tolerance requires internalization of Chylomicron-Bound LPS into hepatocytes. J. Surg. Res. 115: 303-309. (Pubitemid 38021922)
57. Cruz, D. N., M. A. Perazella, R. Bellomo, M. de Cal, N. Polanco, V. Corradi, P. Lentini, F. Nalesso, T. Ueno, V. M. Ranieri, and C. Ronco. 2007. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit. Care 11: R47.
58. Craciun, F. L., E. R. Schuller, and D. G. Remick. 2010. Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival. J. Immunol. 185: 6930-6938.
59. Cruz, D. N., M. Antonelli, R. Fumagalli, F. Foltran, N. Brienza, A. Donati, V. Malcangi, F. Petrini, G. Volta, F. M. Bobbio Pallavicini, et al. 2009. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301: 2445-2452.
60. Rice, T. W., A. P. Wheeler, G. R. Bernard, J. L. Vincent, D. C. Angus, N. Aikawa, I. Demeyer, S. Sainati, N. Amlot, C. Cao, et al. 2010. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit. Care Med. 38: 1685-1694.